Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Fischer

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Structure (London, England : 1993)|April 8, 2003
Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loopSu Ying Wu, Iain McNae, George Kontopidis, et al.
International Journal of Pharmaceutics|June 26, 2022
Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiolWanshan Feng, Chaolong Qin, Salah Abdelrazig, et al.
Journal of Medicinal Chemistry|January 11, 2013
Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activitiesHao Shao, Shenhua Shi, Shiliang Huang, et al.
Structure (London, England : 1993)|December 6, 2003
Insights into cyclin groove recognition: complex crystal structures and inhibitor design through ligand exchangeGeorge Kontopidis, Martin J I Andrews, Campbell McInnes, et al.
Journal of Medicinal Chemistry|February 12, 2010
Design, synthesis, and evaluation of 2-methyl- and 2-amino-N-aryl-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amines as ring-constrained 2-anilino-4-(thiazol-5-yl)pyrimidine cyclin-dependent kinase inhibitorsNeil A McIntyre, Campbell McInnes, Gary Griffiths, et al.
Elife|May 21, 2020
Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex IZoe A Stephenson, Robert F Harvey, Kenneth R Pryde, et al.
Scientific Reports|November 8, 2017
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulationAtheer Zgair, Jong Bong Lee, Jonathan C M Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202Florence I Raynaud, Steven R Whittaker, Peter M Fischer, et al.
Journal of Medicinal Chemistry|March 19, 2004
2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activityShudong Wang, Christopher Meades, Gavin Wood, et al.
Scientific Reports|November 2, 2019
A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepinJong Bong Lee, Masar Radhi, Elena Cipolla, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Structure (London, England : 1993)|April 8, 2003
Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loopSu Ying Wu, Iain McNae, George Kontopidis, et al.
International Journal of Pharmaceutics|June 26, 2022
Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiolWanshan Feng, Chaolong Qin, Salah Abdelrazig, et al.
Journal of Medicinal Chemistry|January 11, 2013
Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activitiesHao Shao, Shenhua Shi, Shiliang Huang, et al.
Structure (London, England : 1993)|December 6, 2003
Insights into cyclin groove recognition: complex crystal structures and inhibitor design through ligand exchangeGeorge Kontopidis, Martin J I Andrews, Campbell McInnes, et al.
Journal of Medicinal Chemistry|February 12, 2010
Design, synthesis, and evaluation of 2-methyl- and 2-amino-N-aryl-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amines as ring-constrained 2-anilino-4-(thiazol-5-yl)pyrimidine cyclin-dependent kinase inhibitorsNeil A McIntyre, Campbell McInnes, Gary Griffiths, et al.
Elife|May 21, 2020
Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex IZoe A Stephenson, Robert F Harvey, Kenneth R Pryde, et al.
Scientific Reports|November 8, 2017
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulationAtheer Zgair, Jong Bong Lee, Jonathan C M Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202Florence I Raynaud, Steven R Whittaker, Peter M Fischer, et al.
Journal of Medicinal Chemistry|March 19, 2004
2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activityShudong Wang, Christopher Meades, Gavin Wood, et al.
Scientific Reports|November 2, 2019
A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepinJong Bong Lee, Masar Radhi, Elena Cipolla, et al.
Pageof 12